These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

421 related items for PubMed ID: 34225748

  • 21. Assessment of immune status against measles, mumps, and rubella in young Kuwaitis: MMR vaccine efficacy.
    Madi N, Altawalah H, Alfouzan W, Al-Nakib W, Al-Roumi E, Jeragh A.
    J Med Virol; 2020 Aug; 92(8):963-970. PubMed ID: 31919861
    [Abstract] [Full Text] [Related]

  • 22. Immune response after primary and re-vaccination with different combined vaccines against measles, mumps, rubella.
    Tischer A, Gerike E.
    Vaccine; 2000 Jan 31; 18(14):1382-92. PubMed ID: 10618536
    [Abstract] [Full Text] [Related]

  • 23. Parental Vaccine Hesitancy and Association With Childhood Diphtheria, Tetanus Toxoid, and Acellular Pertussis; Measles, Mumps, and Rubella; Rotavirus; and Combined 7-Series Vaccination.
    Nguyen KH, Srivastav A, Lindley MC, Fisher A, Kim D, Greby SM, Lee J, Singleton JA.
    Am J Prev Med; 2022 Mar 31; 62(3):367-376. PubMed ID: 35190101
    [Abstract] [Full Text] [Related]

  • 24. Prevalence of anti-gelatin IgE antibodies in people with anaphylaxis after measles-mumps rubella vaccine in the United States.
    Pool V, Braun MM, Kelso JM, Mootrey G, Chen RT, Yunginger JW, Jacobson RM, Gargiullo PM, VAERS Team. US Vaccine Adverse Event Reporting System.
    Pediatrics; 2002 Dec 31; 110(6):e71. PubMed ID: 12456938
    [Abstract] [Full Text] [Related]

  • 25. Two-year antibody persistence in children vaccinated at 12-15 months with a measles-mumps-rubella virus vaccine without human serum albumin.
    Berry AA, Abu-Elyazeed R, Diaz-Perez C, Mufson MA, Harrison CJ, Leonardi M, Twiggs JD, Peltier C, Grogg S, Carbayo A, Shapiro S, Povey M, Baccarini C, Innis BL, Henry O.
    Hum Vaccin Immunother; 2017 Jul 03; 13(7):1516-1522. PubMed ID: 28481690
    [Abstract] [Full Text] [Related]

  • 26. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy.
    Zignol M, Peracchi M, Tridello G, Pillon M, Fregonese F, D'Elia R, Zanesco L, Cesaro S.
    Cancer; 2004 Aug 01; 101(3):635-41. PubMed ID: 15274078
    [Abstract] [Full Text] [Related]

  • 27. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K, Nicoara C, Germann D, Matter L.
    Schweiz Med Wochenschr; 1998 Apr 25; 128(17):649-57. PubMed ID: 9622837
    [Abstract] [Full Text] [Related]

  • 28. Antibodies to measles, mumps, and rubella virus in Thai children after two-dose vaccination at 9 months and 2.5 years: A longitudinal study.
    Wanlapakorn N, Puenpa J, Thongmee T, Srimuan D, Thatsanathorn T, Vongpunsawad S, Poovorawan Y.
    Vaccine; 2020 May 19; 38(24):4016-4023. PubMed ID: 32331806
    [Abstract] [Full Text] [Related]

  • 29. Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy.
    Sultana R, Rahman MM, Hassan Z, Hassan MS.
    Scand J Immunol; 2006 Dec 19; 64(6):684-9. PubMed ID: 17083626
    [Abstract] [Full Text] [Related]

  • 30. Immunogenicity and safety of early vaccination with two doses of a combined measles-mumps-rubella-varicella vaccine in healthy Indian children from 9 months of age: a phase III, randomised, non-inferiority trial.
    Lalwani S, Chatterjee S, Balasubramanian S, Bavdekar A, Mehta S, Datta S, Povey M, Henry O.
    BMJ Open; 2015 Sep 11; 5(9):e007202. PubMed ID: 26362659
    [Abstract] [Full Text] [Related]

  • 31. Measles, mumps, rubella prevention: how can we do better?
    Kauffmann F, Heffernan C, Meurice F, Ota MOC, Vetter V, Casabona G.
    Expert Rev Vaccines; 2021 Jul 11; 20(7):811-826. PubMed ID: 34096442
    [Abstract] [Full Text] [Related]

  • 32. [Study of mumps immunity after administrating measles-mumps-rubella vaccine among children aged 2-7 years old in Jiangsu Province in 2015].
    Liu YB, Hu Y, Deng XY, Wang ZG, Sun X, Lu PS, Guo HX, Tang FY, Zhou MH.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jul 06; 51(7):593-597. PubMed ID: 28693082
    [Abstract] [Full Text] [Related]

  • 33. Antibody persistence for 3 years following two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children.
    Knuf M, Zepp F, Helm K, Maurer H, Prieler A, Kieninger-Baum D, Douha M, Willems P.
    Eur J Pediatr; 2012 Mar 06; 171(3):463-70. PubMed ID: 21935584
    [Abstract] [Full Text] [Related]

  • 34. Age-stratified seroprevalence of measles, mumps and rubella (MMR) virus infections in Switzerland after the introduction of MMR mass vaccination.
    Matter L, Germann D, Bally F, Schopfer K.
    Eur J Epidemiol; 1997 Jan 06; 13(1):61-6. PubMed ID: 9062781
    [Abstract] [Full Text] [Related]

  • 35. Coverage rates of the children vaccination programme in Greenland.
    Albertsen N, Lynge AR, Skovgaard N, Olesen JS, Pedersen ML.
    Int J Circumpolar Health; 2020 Dec 06; 79(1):1721983. PubMed ID: 32000619
    [Abstract] [Full Text] [Related]

  • 36. Mumps, measles and rubella vaccination in children with PFAPA syndrome.
    Kraszewska-Głomba B, Matkowska-Kocjan A, Miśkiewicz K, Szymańska-Toczek Z, Wójcik M, Banyś D, Szenborn L.
    Vaccine; 2016 Nov 21; 34(48):5903-5906. PubMed ID: 27997341
    [Abstract] [Full Text] [Related]

  • 37. IgG antibody prevalence suggests high immunization needs in newcomers to Luxembourg, 2012.
    Hübschen JM, Charpentier E, Weicherding P, Muller CP.
    Vaccine; 2018 Feb 01; 36(6):899-905. PubMed ID: 29306505
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2017.
    Walker TY, Elam-Evans LD, Yankey D, Markowitz LE, Williams CL, Mbaeyi SA, Fredua B, Stokley S.
    MMWR Morb Mortal Wkly Rep; 2018 Aug 24; 67(33):909-917. PubMed ID: 30138305
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.